• Washington DC |
  • New York |
  • Toronto |
  • Distribution: (800) 510 9863
Tuesday, November 17, 2026
  • Login
No Result
View All Result
NEWSLETTER
New Edge Times
  • World
  • U.S.
  • Politics
  • Business
  • Science
  • Tech
  • Youth
  • Entertainment
    • All
    • Arts
    • Gaming
    • Movie
    • Music
    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    After ‘Boston,’ Where Does Stella Lefty Go?

    After ‘Boston,’ Where Does Stella Lefty Go?

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    5 Takeaways From the 2027 Grammy Nominations.

    5 Takeaways From the 2027 Grammy Nominations.

    Why Robert Pattinson Could Be a Great James Bond

    Why Robert Pattinson Could Be a Great James Bond

    • Gaming
    • Movie
    • Music
    • Arts
  • Sports
  • Lifestyle
    • All
    • Fashion
    • Food
    • Health
    • Travel
    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    And Now, Melissa Clark’s Mashed Potatoes

    And Now, Melissa Clark’s Mashed Potatoes

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    How the Measles Virus Makes Your Immune System Forget

    How the Measles Virus Makes Your Immune System Forget

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    A Hot Springs Road Trip in Southern California

    A Hot Springs Road Trip in Southern California

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    • Fashion
    • Food
    • Health
    • Travel
  • Reviews
  • Trending
  • World
  • U.S.
  • Politics
  • Business
  • Science
  • Tech
  • Youth
  • Entertainment
    • All
    • Arts
    • Gaming
    • Movie
    • Music
    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    Review: Asmik Grigorian Stars in a New Met Opera ‘Jenufa’

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    ‘The Hunger Games: Sunrise on the Reaping’ Review: Another Tribute

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Video: Will A.I. Make This Tedious Hollywood Job Easier?

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    Anne Teresa De Keersmaeker Comes Full Circle, Spinning to Philip Glass

    After ‘Boston,’ Where Does Stella Lefty Go?

    After ‘Boston,’ Where Does Stella Lefty Go?

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    ‘The Fantasticks’ Review: A Gender Swap for a Still-Tender Story

    5 Takeaways From the 2027 Grammy Nominations.

    5 Takeaways From the 2027 Grammy Nominations.

    Why Robert Pattinson Could Be a Great James Bond

    Why Robert Pattinson Could Be a Great James Bond

    • Gaming
    • Movie
    • Music
    • Arts
  • Sports
  • Lifestyle
    • All
    • Fashion
    • Food
    • Health
    • Travel
    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    Street Style Look of the Week: ‘Old Man’ Style and ‘Subliminal Messaging’

    And Now, Melissa Clark’s Mashed Potatoes

    And Now, Melissa Clark’s Mashed Potatoes

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Restaurant Review: At Faux, the Scene-y NYC Bistro Enters Its Next Generation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    Jessica Craig-Martin Is Thrilled to Decline an Invitation

    How the Measles Virus Makes Your Immune System Forget

    How the Measles Virus Makes Your Immune System Forget

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

    A Hot Springs Road Trip in Southern California

    A Hot Springs Road Trip in Southern California

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    Pilots Kept Contact With Controllers During Nationwide Halt to Flights

    • Fashion
    • Food
    • Health
    • Travel
  • Reviews
  • Trending
No Result
View All Result
New Edge Times
No Result
View All Result
Home Trending

J & J COVID vaccine use is restricted by FDA due to blood clot risk

by New Edge Times Report
May 6, 2022
in Trending
J & J COVID vaccine use is restricted by FDA due to blood clot risk
Share on FacebookShare on Twitter

The Food and Drug Administration put rigid limits on who can receive Johnson & Johnson’s one-dose COVID-19 vaccine on Thursday, saying the vaccine should only be given to people who cannot receive a different vaccine or those who specifically request it.

After the single-dose vaccine was authorized in February 2021, the FDA and Centers for Disease Control and Prevention temporarily paused administering the shot in April after reports of blood clots in a small number of people who received it. The pause was lifted 11 days later, with the health agencies determining the benefits of the J&J vaccine outweighed the risks.

But the FDA has reversed course, ruling the risks of the side effect, called thrombosis with thrombocytopenia syndrome, outweigh the benefits. The condition, also known as vaccine-induced thrombatic thrombocytopenia, is the combination of a blood clot with low platelet count. The blood clots form in unusual places, such as veins that drain blood from the brain.

Until late 2021, the U.S. had treated all three COVID-19 vaccines available to Americans – Pfizer, Moderna, and Johnson & Johnson – as an equal choice, since large studies found they all offered strong protection and early supplies were limited. But in December of last year, the CDC officially recommended the Pfizer and Moderna COVID vaccines over J&J’s.

Thursday’s decision goes one step further, formally limiting the vaccine’s use.

‘THIS IS HAPPENING!’:Husband defends COVID vaccines after wife dies from rare Johnson & Johnson shot complications

FDA vaccine chief Dr. Peter Marks said the agency made the decision after re-examining the data on the risks of life-threatening blood clots, concluding that they are limited to J&J’s vaccine.

“If there’s an alternative that appears to be equally effective in preventing severe outcomes from COVID-19, we’d rather see people opting for that,” Marks said. “But we’ve been careful to say that — compared to no vaccine — this is still a better option.”

The problem occurs in the first two weeks after vaccination, he added: “So if you had the vaccine six months ago you can sleep soundly tonight knowing this isn’t an issue.”

Out of the about 17 million Americans who received the J&J shot, federal scientists had identified 60 cases of the side effect, including nine that were fatal, as of mid-March. That amounts to 3.23 blood clot cases per 1 million J&J shots. The problem is more common in women under 50, where the death rate was roughly 1 per million shots, according to Marks.

Following the FDA’s decision, the J&J vaccine will now carry the warning of potential “long-term and debilitating health consequences” of the side effect.

COVID PANDEMIC:Pfizer-BioNTech requests FDA authorization for fourth COVID vaccine shot for 65 and older

A J&J spokesman said in an emailed statement: “Data continue to support a favorable benefit-risk profile for the Johnson & Johnson COVID-19 vaccine in adults, when compared with no vaccine.”

More than 200 million Americans have received Moderna’s and Pfizer’s two-dose shots, compared to J&J’s 17 million.

Contributing: Elizabeth Weise and Karen Weintraub, USA TODAY; The Associated Press

Previous Post

Moderna seeks FDA OK for COVID vaccine in 6 month to under 6 year olds

Next Post

66% of working parents have burnout, study suggests

Related Posts

A Distinctive Perspective of Creativity in Professional Life
Trending

A Distinctive Perspective of Creativity in Professional Life

by New Edge Times Report
May 7, 2026
Why Everyone in Toronto Is Talking About Kyle Nunes Medeiros Right Now
Trending

Why Everyone in Toronto Is Talking About Kyle Nunes Medeiros Right Now

by New Edge Times Report
May 4, 2026
Magic Susan Introduces the World’s First Smart Entryway Organizer with AI Contextual Awareness
Trending

Magic Susan Introduces the World’s First Smart Entryway Organizer with AI Contextual Awareness

by New Edge Times Report
May 2, 2026
Leave Comment
New Edge Times

© 2025 New Edge Times or its affiliated companies. All rights reserved.

Navigate Site

  • About
  • Advertise
  • Terms & Conditions
  • Privacy Policy
  • Disclaimer
  • Contact

Follow Us

No Result
View All Result
  • World
  • U.S.
  • Politics
  • Business
  • Science
  • Tech
  • Youth
  • Entertainment
    • Gaming
    • Movie
    • Music
    • Arts
  • Sports
  • Lifestyle
    • Fashion
    • Food
    • Health
    • Travel
  • Reviews
  • Trending

© 2025 New Edge Times or its affiliated companies. All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In